BR0115188A - Process for the preparation of latent antithrombin iii - Google Patents

Process for the preparation of latent antithrombin iii

Info

Publication number
BR0115188A
BR0115188A BR0115188-6A BR0115188A BR0115188A BR 0115188 A BR0115188 A BR 0115188A BR 0115188 A BR0115188 A BR 0115188A BR 0115188 A BR0115188 A BR 0115188A
Authority
BR
Brazil
Prior art keywords
preparation
antithrombin iii
latent
latent antithrombin
iii
Prior art date
Application number
BR0115188-6A
Other languages
Portuguese (pt)
Inventor
Goran Karlsson
Original Assignee
Octopharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0004086A external-priority patent/SE0004086D0/en
Application filed by Octopharma Ag filed Critical Octopharma Ag
Publication of BR0115188A publication Critical patent/BR0115188A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • C07K14/8128Antithrombin III
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Abstract

"PROCESSO PARA A PREPARAçãO DE ANTI-TROMBINA III LATENTE". A invenção refere-se a um processo para a preparação de anti-trombina III latente. O processo compreende incubação de uma solução de antitrombina III nativa na presença de íons de sulfato e um tampão selecionado de tampões zwiteriónicos de Good."PROCESS FOR PREPARATION OF LATENT ANTI-THROMBIN III". The invention relates to a process for the preparation of latent anti-thrombin III. The process comprises incubating a native antithrombin III solution in the presence of sulfate ions and a buffer selected from Good zwitterionic buffers.

BR0115188-6A 2000-11-08 2001-11-08 Process for the preparation of latent antithrombin iii BR0115188A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0004086A SE0004086D0 (en) 2000-11-08 2000-11-08 Preparation process
US25214800P 2000-11-20 2000-11-20
PCT/SE2001/002473 WO2002038610A1 (en) 2000-11-08 2001-11-08 Process for the preparation of latent antithrombin iii

Publications (1)

Publication Number Publication Date
BR0115188A true BR0115188A (en) 2004-02-03

Family

ID=26655296

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0115188-6A BR0115188A (en) 2000-11-08 2001-11-08 Process for the preparation of latent antithrombin iii

Country Status (15)

Country Link
EP (1) EP1332159A1 (en)
JP (1) JP2004522707A (en)
KR (1) KR20030057545A (en)
AU (1) AU2002214468A1 (en)
BR (1) BR0115188A (en)
CA (1) CA2428055A1 (en)
CZ (1) CZ20031277A3 (en)
EE (1) EE200300218A (en)
HU (1) HUP0301766A3 (en)
IL (1) IL155539A0 (en)
MX (1) MXPA03004030A (en)
NO (1) NO20032048L (en)
PL (1) PL360410A1 (en)
RU (1) RU2003117016A (en)
WO (1) WO2002038610A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
SE0203770D0 (en) * 2002-12-19 2002-12-19 Biovitrum Ab Method of separation
EP1848473B1 (en) 2005-02-07 2013-05-22 Hanuman LLC Plasma concentrator device
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US7806276B2 (en) 2007-04-12 2010-10-05 Hanuman, Llc Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
WO2009108890A1 (en) 2008-02-27 2009-09-03 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
WO2009111338A1 (en) 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device

Also Published As

Publication number Publication date
CA2428055A1 (en) 2002-05-16
HUP0301766A3 (en) 2005-12-28
RU2003117016A (en) 2004-12-10
PL360410A1 (en) 2004-09-06
MXPA03004030A (en) 2004-02-12
JP2004522707A (en) 2004-07-29
AU2002214468A1 (en) 2002-05-21
EE200300218A (en) 2003-08-15
EP1332159A1 (en) 2003-08-06
NO20032048D0 (en) 2003-05-07
HUP0301766A2 (en) 2003-08-28
NO20032048L (en) 2003-05-07
CZ20031277A3 (en) 2003-08-13
KR20030057545A (en) 2003-07-04
WO2002038610A1 (en) 2002-05-16
IL155539A0 (en) 2003-11-23

Similar Documents

Publication Publication Date Title
BR0115188A (en) Process for the preparation of latent antithrombin iii
DK1255826T3 (en) Automation of protein design for protein libraries
BR9908020A (en) Optical polishing formula
PT1465864E (en) INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE CASCADE OF COAGULACAO
BR9913383A (en) Pyrazole-carboxanilides
BRPI9915679A8 (en) COMPOSITIONS AND METHODS TO INCREASE BONE MINERALIZATION
EA200200940A1 (en) DERIVATIVES OF AZETIDINE, METHOD OF THEIR PRODUCTION AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
BRPI9910332B8 (en) method for purifying a polypeptide from a composition
BR0116047A (en) Heterocyclic Ether Substituted Imidazoquinolines
ATE424413T1 (en) ANALOGUE OF GLUCAGONE-LIKE PEPTIDE-1
BR0203112A (en) Organopolysiloxanes presenting quaternary ammonium groups and process for their preparation
BR0012750A (en) Cleaning agent for glassy ceramic surfaces
BR9711117A (en) Modified oligosaccharides.
BRPI0603197A (en) toner composition
PT1087914E (en) SOLUBLE GLASS COMPOSITIONS IN WATER
BR9911978A (en) Substituted phenyluracils
BR0111147B1 (en) process of preparing a tissue conditioning composition.
FR2832403B1 (en) NON-SHAPED REFRACTORY COMPOSITION, IN PARTICULAR FOR THE PRODUCTION OF SOLES FROM A GLASS FURNACE
WO2003051927A3 (en) Production of f(ab')2 fragments in mammalian cells
BR9608925A (en) Cleaning composition and process for cleaning delicate surfaces
BR0013084A (en) Heterocyclyl-2h-substituted chromenes
SE0004086D0 (en) Preparation process
BR0007183A (en) Isonipectoamides for the treatment of integrin-mediated disorders
BR9911977A (en) Substituted acylaminophenyl-uracils
BR0109592A (en) Fluorescent Contact Lenses

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]